Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)

CNY 35.67

(0.08%)

Total Liabilities Summary of Tibet Rhodiola Pharmaceutical Holding Co.

  • Tibet Rhodiola Pharmaceutical Holding Co.'s latest annual total liabilities in 2023 was 1.18 Billion CNY , up 11.16% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co.'s latest quarterly total liabilities in 2024 Q2 was 1.51 Billion CNY , up 8.1% from previous quarter.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported annual total liabilities of 1.06 Billion CNY in 2022, down -7.69% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported annual total liabilities of 1.15 Billion CNY in 2021, up 225.26% from previous year.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly total liabilities of 1 Billion CNY for 2024 Q3, down -33.32% from previous quarter.
  • Tibet Rhodiola Pharmaceutical Holding Co. reported quarterly total liabilities of 1.51 Billion CNY for 2024 Q2, up 8.1% from previous quarter.

Annual Total Liabilities Chart of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Historical Annual Total Liabilities of Tibet Rhodiola Pharmaceutical Holding Co. (2023 - 1996)

Year Total Liabilities Total Liabilities Growth
2023 1.18 Billion CNY 11.16%
2022 1.06 Billion CNY -7.69%
2021 1.15 Billion CNY 225.26%
2020 355.9 Million CNY 11.07%
2019 320.44 Million CNY 16.57%
2018 274.89 Million CNY -3.42%
2017 284.64 Million CNY -82.56%
2016 1.63 Billion CNY 640.59%
2015 220.42 Million CNY -65.14%
2014 632.26 Million CNY -14.36%
2013 738.25 Million CNY 60.59%
2012 459.71 Million CNY 6.19%
2011 432.92 Million CNY 5.26%
2010 411.28 Million CNY -7.31%
2009 443.7 Million CNY -19.4%
2008 550.5 Million CNY -1.29%
2007 557.68 Million CNY 18.51%
2006 470.55 Million CNY 10.11%
2005 427.36 Million CNY 25.06%
2004 341.74 Million CNY 3.61%
2003 329.82 Million CNY 4.96%
2002 314.23 Million CNY 55.7%
2001 201.82 Million CNY 60.16%
2000 126.01 Million CNY 169.65%
1999 46.73 Million CNY -34.8%
1998 71.67 Million CNY 108.83%
1997 34.32 Million CNY 17.23%
1996 29.27 Million CNY 0.0%

Peer Total Liabilities Comparison of Tibet Rhodiola Pharmaceutical Holding Co.

Name Total Liabilities Total Liabilities Difference
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 25.966%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -164.446%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -169.408%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -73.105%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 46.918%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -71.283%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 67.448%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -175.566%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 25.944%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 65.985%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY -38.073%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 75.714%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 74.74%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -181.261%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY -15.127%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -172.108%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 87.094%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 22.869%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -296.954%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -70.635%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 69.582%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -149.599%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 20.397%
Guobang Pharma Ltd. 2.92 Billion CNY 59.381%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -1009.618%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 47.069%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 85.808%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 87.722%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 39.8%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 69.268%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 83.501%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 73.157%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 92.28%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 50.161%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -152.674%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 28.013%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY -23.787%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 39.089%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 46.245%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -1181.304%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 76.003%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 73.916%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY -16.915%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY -47.424%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 57.472%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 88.522%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 37.244%
CanSino Biologics Inc. 3.86 Billion CNY 69.269%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY -33.934%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 26.158%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -231.103%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 19.339%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 64.95%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 91.101%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 91.911%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 66.312%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 87.177%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 88.715%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 97.096%
China National Medicines Corporation Ltd. 14.87 Billion CNY 92.014%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -130.222%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 24.405%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 97.908%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 67.618%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 11.246%